Understanding the Role of Mutations in SF3B1 and Splicing in Chronic Lymphocytic Leukemia

被引：0
|
作者：
Wu, Catherine J. [1 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
15
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Clinical impact of small subclones harboring NOTCH1, SF3B1 or BIRC3 mutations In chronic lymphocytic leukemia
    Rasi, Silvia
    Khiabanian, Hossein
    Ciardullo, Carmela
    Terzi-di-Bergamo, Lodovico
    Monti, Sara
    Spina, Valeria
    Bruscaggin, Alessio
    Cerri, Michaela
    Deambrogi, Clara
    Martuscelli, Lavinia
    Biasi, Alessandra
    Spaccarotella, Elisa
    De Paoli, Lorenzo
    Gattei, Valter
    Foa, Robin
    Rabadan, Raul
    Gaidano, Gianluca
    Rossi, Davide
    HAEMATOLOGICA, 2016, 101 (04)
  • [32] SMALL SUBCLONES HARBORING NOTCH1, SF3B1 OR BIRC3 MUTATIONS ARE CLINICALLY IRRELEVANT IN CHRONIC LYMPHOCYTIC LEUKEMIA
    Bruscaggin, A.
    Rasi, S.
    Ciardullo, C.
    Khiabanian, H.
    Terzi-di-Bergamo, L.
    Monti, S.
    Spina, V.
    Biasi, A.
    De Paoli, L.
    Gattei, V.
    Foa, R.
    Rabadan, R.
    Rossi, D.
    Gaidano, G.
    HAEMATOLOGICA, 2015, 100 : 28 - 28
  • [33] NOTCH1, SF3B1, MDM2 and MYD88 mutations in patients with chronic lymphocytic leukemia
    Maleki, Yosra
    Alahbakhshi, Zahra
    Heidari, Zahra
    Moradi, Mohammad-Taher
    Rahimi, Ziba
    Yari, Kheirolah
    Rahimi, Zohreh
    Aznab, Mozafar
    Ahmadi-Khajevand, Meisam
    Bahremand, Fariborz
    ONCOLOGY LETTERS, 2019, 17 (04) : 4016 - 4023
  • [34] SF3B1 Mutations Are Associated with Resistance to Non-Genotoxic MDM2 Inhibition in Chronic Lymphocytic Leukemia
    Aptullahoglu, Erhan
    Wallis, Jonathan P.
    Marr, Helen
    Marshall, Scott
    Bown, Nick
    Willmore, Elaine
    Lunec, John
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (14)
  • [35] SF3B1 MUTATIONS INDUCE COMMON AND LINEAGE SPECIFIC ABERRANT MESSENGER RNA SPLICING IN MALIGNANCIES INCLUDING CHRONIC LYMPHOCYTIC LEUKEMIA AND CONFER SENSITIVITY TO SPLICEOSOME INHIBITION
    Buonamici, S.
    Lim, K. H.
    Feala, J.
    Park, E.
    Corson, L.
    Aicher, M.
    Aird, D.
    Berkenblit, A.
    Chan, B.
    Corcoran, E.
    Darman, R.
    Fekkes, P.
    Furman, R. R.
    Keaney, G.
    Kumar, P.
    Kunii, K.
    Lee, L.
    Puyang, X.
    Rodrigues, J.
    Selvaraj, A.
    Thomas, M.
    Wang, J.
    Warmuth, M.
    Yu, L.
    Zhu, P.
    Mizui, Y.
    Smith, P.
    HAEMATOLOGICA, 2014, 99 : 227 - 227
  • [36] Transcriptomic Characterization of SF3B1 Mutation Reveals Its Pleiotropic Effects in Chronic Lymphocytic Leukemia
    Wang, Lili
    Brooks, Angela N.
    Fan, Jean
    Wan, Youzhong
    Gambe, Rutendo
    Li, Shuqiang
    Hergert, Sarah
    Yin, Shanye
    Freeman, Samuel S.
    Levin, Joshua Z.
    Fan, Lin
    Seiler, Michael
    Buonamici, Silvia
    Smith, Peter G.
    Chau, Kevin F.
    Cibulskis, Carrie L.
    Zhang, Wandi
    Rassenti, Laura Z.
    Ghia, Emanuela M.
    Kipps, Thomas J.
    Fernandes, Stacey
    Bloch, Donald B.
    Kotliar, Dylan
    Landau, Dan A.
    Shukla, Sachet A.
    Aster, Jon C.
    Reed, Robin
    DeLuca, David S.
    Brown, Jennifer R.
    Neuberg, Donna
    Getz, Gad
    Livak, Kenneth J.
    Meyerson, Matthew M.
    Kharchenko, Peter V.
    Wu, Catherine J.
    CANCER CELL, 2016, 30 (05) : 750 - 763
  • [37] Potential role of the splicing factor SF3B1 in epigenetic regulation
    Deliard, Sandra
    Okamoto, Yasuyuki
    Madzo, Jozef
    Jelinek, Jaroslav
    Issa, Jean-Pierre
    CANCER RESEARCH, 2017, 77
  • [38] Splicing Factor 3B Subunit 1 (SF3B1) Mutations Impact FOXP1 Splicing in Chronic Lymphocytic Leukemia (CLL) Cells but Conserve the Balance Between Newly Described and Classical Splicing Variants of ZAP-70
    Roudot, Herve
    Martret, Jennifer
    Baran-Marszak, Fanny
    Collon, Jean Francois
    Dahmani, Abdemalek
    Lefebvre, Valerie
    Troussard, Xavier
    Cymbalista, Florence
    Varin-Blank, Nadine
    Letestu, Remi
    BLOOD, 2015, 126 (23)
  • [39] Mutations in chronic lymphocytic leukemia and how they affect therapy choice: focus on NOTCH1, SF3B1, and TP53
    Zent, Clive S.
    Burack, W. Richard
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2014, : 119 - 124
  • [40] Clinical Impact of Clonal and Subclonal TP53, SF3B1, BIRC3, and ATM Mutations in Chronic Lymphocytic Leukemia
    Nadeu, Ferran
    Delgado, Julio
    Royo, Cristina
    Bauman, Tycho
    Stankovic, Tatjana
    Pinyol, Magda
    Jares, Pedro
    Navarro, Alba
    Martin-Garcia, David
    Bea, Silvia
    Salaverria, Itziar
    Oldreive, Ceri
    Aymerich, Marta
    Suarez-Cisneros, Helena
    Rozman, Maria
    Villamor, Neus
    Colomer, Dolors
    Lopez-Guillermo, Armando
    Gonzalez, Marcos
    Alcoceba, Miguel
    Jose Terol, Maria
    Colado, Enrique
    Puente, Xose S.
    Lopez-Otin, Carlos
    Enjuanes, Anna
    Campo, Elias
    BLOOD, 2015, 126 (23)
12345